Lv41
626 积分 2023-11-08 加入
ScFv Improvement Approaches
4个月前
已完结
Reducing affinity as a strategy to boost immunomodulatory antibody agonism
4个月前
已完结
Template-free antibody design
8个月前
已完结
Therapeutic Antibody Engineering and Selection Strategies
8个月前
已完结
Engineering a bispecific antibody with a common light chain: Identification and optimization of an anti-CD3 epsilon and anti-GPC3 bispecific antibody, ERY974
8个月前
已完结
皖公网安备34019202002308
